Home/Filings/4/0001415889-24-010291
4//SEC Filing

SMITH PATRICK F 4

Accession 0001415889-24-010291

CIK 0001827090other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 4:45 PM ET

Size

15.1 KB

Accession

0001415889-24-010291

Insider Transaction Report

Form 4
Period: 2024-04-02
SMITH PATRICK F
PRESIDENT, INTEGRATED DRUG DEV
Transactions
  • Sale

    Common Stock

    2024-04-02$17.67/sh328$5,79655,253 total
  • Sale

    Common Stock

    2024-04-02$16.77/sh4,740$79,49050,513 total
  • Sale

    Common Stock

    2024-04-02$17.77/sh422$7,49950,091 total
  • Sale

    Common Stock

    2024-04-02$16.76/sh5,264$88,22559,254 total
  • Sale

    Common Stock

    2024-04-02$17.72/sh649$11,50058,605 total
  • Sale

    Common Stock

    2024-04-02$16.75/sh3,024$50,65255,581 total
Footnotes (7)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2023.
  • [F2]This transaction was executed in multiple trades at prices ranging from $16.50 to $16.98. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]This transaction was executed in multiple trades at prices ranging from $17.53 to $17.85. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]This transaction was executed in multiple trades at prices ranging from $16.49 to $16.96. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F5]This transaction was executed in multiple trades at prices ranging from $17.53 to $17.74. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F6]This transaction was executed in multiple trades at prices ranging from $16.50 to $17.11. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F7]This transaction was executed in multiple trades at prices ranging from $17.70 to $17.85. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

Certara, Inc.

CIK 0001827090

Entity typeother

Related Parties

1
  • filerCIK 0001890360

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:45 PM ET
Size
15.1 KB